-
LRG1 and Neutrophil Mitochondria in Bladder Cancer
2026-09-02
The Advanced Science study identifies an LRG1–ANXA2–neutrophil pathway that links tumor-derived LRG1 to mitochondrial stress, NET release, vascular destabilization, and treatment resistance in bladder cancer. Its integrated single-cell, molecular, and in vivo strategy suggests that disrupting NETosis may normalize tumor vessels and improve responses to cisplatin and anti-PD-1 therapy.
-
Non-Betalain DODA and Stress Adaptation in Pansy
2026-09-02
A 2025 study shows that VwDODA, a non-betalain DODA homolog from pansy, has a stress-related metabolic role rather than a canonical pigment-producing function. Through biochemical, heterologous-expression, and promoter analyses, the authors link VwDODA to salt tolerance, pathogen resistance, antioxidant defense, ABA signaling, and VwMYB20-associated regulation.
-
PPT (Propyl Pyrazole Triol): ERα Research Guide
2026-09-01
PPT (Propyl Pyrazole Triol) is a potent, selective ERα agonist for separating estrogen receptor alpha signaling from ERβ activity in research models. B6735 combines strong reported subtype preference with defined solvent, storage, gene-expression, and uterotrophic assay information.
-
BCL6–ESM1 Axis in Hepatocellular Carcinoma Immunity
2026-09-01
The reference study identifies cancer-cell BCL6 as an immune-evasion regulator in hepatocellular carcinoma, linking reduced inflammatory signaling and increased ESM1 to impaired tumor-infiltrating CD4+ T-cell recruitment and cytotoxicity. Its findings shift attention beyond CD8+ T-cell quantity toward CD4+ T-cell function and suggest a paracrine mechanism that may influence future combination immunotherapy research.
-
Diminazene Aceturate Research Workflows
2026-08-31
Diminazene Aceturate supports two distinct research tracks: trypanosome parasite screening and mechanistic ACE2 activation studies. This workflow-focused guide covers stock preparation, assay design, cross-domain interpretation, and troubleshooting without treating antiparasitic activity as proof of mitochondrial protection.
-
Hexa His tag peptide for cleaner IP workflows
2026-08-31
The Hexa His tag peptide enables antibody-compatible, competitive elution of His-tagged proteins while minimizing immunoglobulin heavy- and light-chain carryover. This practical guide covers assay setup, quantitative starting conditions, interaction studies, troubleshooting, and how emerging sequence-based binding models may inform future validation strategies.
-
DIDS: Chloride Transport Workflows for Cancer Research
2026-08-30
DIDS connects chloride-channel pharmacology with near-death cancer-cell models, enabling researchers to test how mitochondrial death signaling influences prometastatic phenotypes. This guide combines practical dosing, solubility control, orthogonal readouts, and cross-domain applications in vascular, sensory, and neurobiology research.
-
Quizartinib (AC220) AML Workflow Guide
2026-08-29
Build reproducible FLT3 signaling, viability, and xenograft workflows with Quizartinib (AC220), from DMSO stock preparation through orthogonal validation. The guide also shows how lessons from a norovirus secretion study can sharpen assay controls without conflating antiviral biology with AML pharmacology.
-
MFGE8–ANXA1–SMAD2/3 in Pancreatic Fibrosis
2026-08-28
This study presents a multimodal strategy for chronic pancreatitis that combines umbilical cord-derived mesenchymal stem cells, their extracellular vesicles, and recombinant MFGE8 nanoparticles. Its central contribution is the identification of an MFGE8-dependent ANXA1–SMAD2/3 mechanism that links extracellular-vesicle activity to reduced pancreatic stellate-cell fibrosis and improved disease features in mice.
-
SIX1 Drives De Novo Lipogenesis in Liver Cancer
2026-08-28
The reference study identifies SIX1 as a direct transcriptional driver of de novo lipogenesis in liver cancer cells, linking ACLY, FASN, and SCD1 expression to AIB1 and HBO1/KAT7-dependent chromatin regulation. It also defines an insulin-responsive DGUOK-AS1–miR-145-5p–SIX1 axis that connects lipid synthesis with tumor proliferation, invasion, metastasis, and patient prognosis.
-
PRINT: RNA-Mediated Transgene Insertion at Safe Harbors
2026-08-27
Zhang and colleagues introduce PRINT, an RNA-only strategy that repurposes avian R2 retroelement proteins for site-specific transgene insertion at a multicopy human safe-harbor locus. The study combines target-primed reverse transcription with two in vitro transcribed RNAs and reports efficient, substantially full-length insertion in cultured human primary cells without a DNA donor.
-
Tranexamic Acid in Fibrinolysis Research
2026-08-27
Tranexamic Acid connects plasmin biology to practical clot-stability assays and next-generation wound-dressing models. This guide covers concentration planning, assay controls, formulation translation, and troubleshooting for reproducible inhibition of fibrinolysis.
-
Novobiocin Workflows for Antimicrobial Research
2026-08-26
Novobiocin is an aminocoumarin antibiotic that supports comparative bacterial susceptibility testing as well as antiparasitic, antiviral, and host-protein studies. This practical guide converts published staphylococcal findings into reproducible bench workflows, decision points, and troubleshooting strategies.
-
LRG1 and Neutrophil Mitochondria in Bladder Cancer
2026-08-26
This 2026 Advanced Science study identifies a tumor-derived LRG1–ANXA2 interaction that disrupts neutrophil mitochondrial homeostasis, promotes mtROS-dependent NETosis, and destabilizes bladder cancer vasculature. Its findings connect mitochondrial dysfunction with vascular pathology and therapeutic resistance, while suggesting that blocking the LRG1–NETosis axis could improve cisplatin delivery and anti-PD-1 responses.
-
Doxorubicin as a Senescence-Mechanism Probe
2026-08-25
Doxorubicin, also known as Adriamycin, is more than a cytotoxic control: it can help researchers distinguish DNA-damage-driven killing from senescence-associated phenotypes. This guide translates a recent Lactobacillus plantarum nanovesicle study into state-resolved assay design and interpretation.